- Enter the mean arterial pressure (MAP) in mm Hg. If you do not have a MAP, leave it blank and enter the systolic and diastolic pressures — MAP will be computed as DBP + (SBP − DBP)/3.
- Enter the central venous pressure (CVP) in mm Hg to obtain the renal (mean) perfusion pressure (MAP − CVP).
- Optionally enter the intra-abdominal pressure (IAP) in mm Hg to obtain the abdominal perfusion pressure (MAP − IAP) and to stage intra-abdominal hypertension / abdominal compartment syndrome.
- The result box recolours by the most concerning value: aim for a renal perfusion pressure ≥ 60–65 mm Hg and, in intra-abdominal hypertension, an abdominal perfusion pressure ≥ 60 mm Hg.
All computation runs in your browser; no values are stored or transmitted.
When to Use
Use perfusion-pressure thinking in any patient with AKI or worsening kidney function in the setting of congestion, shock, or critical illness — where the question is not simply "is the blood pressure high enough?" but "is the kidney actually being perfused?" The renal perfusion pressure (MAP − CVP) captures the gradient that drives flow through the kidney; a high CVP from venous congestion lowers this gradient even when the MAP looks acceptable. The abdominal perfusion pressure (MAP − IAP) does the same for the splanchnic and renal beds when intra-abdominal pressure is elevated.
Appropriate population
Critically ill and cardiorenal patients with AKI — decompensated heart failure, cardiogenic or distributive shock, sepsis, large-volume resuscitation, post-operative or trauma patients at risk of intra-abdominal hypertension, and any patient with an arterial line plus a CVP (and, for abdominal perfusion pressure, a bladder-pressure IAP measurement). Particularly useful when deciding between giving more fluid/pressor versus decongesting.
When NOT to over-read it
These pressures are surrogates, not flow measurements. CVP is an imperfect estimate of renal venous pressure and is affected by transducer level, PEEP, and tricuspid disease; IAP must be measured correctly (supine, end-expiration, zeroed at the mid-axillary line). The 60–65 mm Hg targets are pragmatic thresholds, not validated outcome endpoints, and individual autoregulation varies (e.g., chronic hypertension shifts the curve). Always integrate with urine output, lactate, echocardiography, and the overall haemodynamic picture rather than chasing a single number.
Pearls & Pitfalls
Venous congestion matters as much as forward pressure
In advanced decompensated heart failure, a high CVP is more tightly linked to worsening renal function than a low cardiac index. Two patients can share the same MAP, but the one with a CVP of 18 has a far lower renal perfusion pressure than the one with a CVP of 6. The therapeutic implication is direct: decongestion (lowering CVP) can improve renal perfusion pressure without touching the MAP.
Bedside framing
Think of the kidney as sitting between an inflow (MAP) and an outflow (CVP, or IAP within the abdomen). Flow depends on the gradient, not the inflow alone. Aim for a renal perfusion pressure of about 60–65 mm Hg; in intra-abdominal hypertension aim for an abdominal perfusion pressure of ≥ 60 mm Hg. When MAP is unavailable, MAP ≈ DBP + (SBP − DBP)/3.
Pitfalls
(1) CVP is a pressure, not a volume — a high CVP signals congestion/impaired outflow, not necessarily fluid overload alone, and a low CVP does not license unlimited fluids. (2) Reflexively raising the MAP with vasopressors while ignoring an elevated CVP can fail to improve, or even worsen, renal perfusion. (3) IAP must be measured properly (supine, end-expiration, ~25 mL instilled, zeroed at the mid-axillary line at the iliac crest) — a falsely high IAP misclassifies abdominal hypertension. (4) IAP > 20 mm Hg with new organ dysfunction is abdominal compartment syndrome and may require urgent decompression, not just a higher MAP target.
Why Use It
Blood pressure alone is a poor proxy for kidney perfusion in the critically ill. A patient can have an acceptable MAP yet still be developing congestive AKI because a high central venous pressure is throttling the gradient across the kidney — and another can be developing abdominal compartment syndrome where a rising intra-abdominal pressure is the dominant insult. Calculating renal and abdominal perfusion pressures reframes the bedside question from "is the pressure high enough?" to "is the kidney actually perfused?", and points to the right lever: sometimes raise the MAP, but often decongest (lower the CVP) or decompress (lower the IAP). This cardiorenal, intensive-nephrology framing helps avoid the trap of reflexively giving fluids or vasopressors to a number that looks normal while the kidney quietly fails.
Renal & Abdominal Perfusion Pressure
Enter the MAP (or the SBP and DBP) together with the CVP to get the renal (mean) perfusion pressure. Optionally add the intra-abdominal pressure to get the abdominal perfusion pressure and stage intra-abdominal hypertension.
⚕ Renal perfusion pressure = MAP − CVP (target ≈ 60–65 mm Hg); abdominal perfusion pressure = MAP − IAP (target ≥ 60 mm Hg in intra-abdominal hypertension). CVP and IAP are imperfect surrogates affected by measurement technique, PEEP, and patient position. These thresholds are pragmatic, not validated outcome endpoints. Interpret alongside urine output, lactate, echocardiography, and the full haemodynamic picture. For licensed clinicians; not a substitute for individualized assessment.
Next Steps
Let the limiting pressure direct the next move — raise inflow, lower outflow, or decompress.
- Renal perfusion pressure ≥ 65 mm Hg: adequate by this surrogate. Confirm with urine output and trends; avoid over-resuscitating to chase a number.
- Renal perfusion pressure 60–65 mm Hg: borderline. Reassess the components — is the CVP elevated (decongest with diuresis or ultrafiltration) or the MAP low (consider a vasopressor)? Re-measure after intervention.
- Renal perfusion pressure < 60 mm Hg: low — congestive AKI risk. If CVP is high, prioritise decongestion; if MAP is low, raise it; usually both. Reassess kidney function and haemodynamics closely.
- IAP > 12 mm Hg: intra-abdominal hypertension — institute medical management (sedation/analgesia, NG/rectal decompression, neuromuscular blockade, avoid over-resuscitation, body positioning) and target an abdominal perfusion pressure ≥ 60 mm Hg.
- IAP > 20 mm Hg with new organ dysfunction: abdominal compartment syndrome — escalate urgently and consider surgical decompression; do not rely on raising the MAP alone.
- Cross-check the components with the mean arterial pressure calculator and estimate volume status with RAP from IVC collapsibility.
Evidence & References
Formulas
| Quantity | Formula |
|---|---|
| MAP (if not measured) | DBP + (SBP − DBP)/3 |
| Renal / mean perfusion pressure | RPP = MAP − CVP |
| Abdominal perfusion pressure | APP = MAP − IAP |
Targets & Staging
| Parameter | Threshold |
|---|---|
| Renal perfusion pressure (MAP − CVP) | Target ≈ 60–65 mm Hg; < 60 = low (congestive AKI risk) |
| Elevated CVP | > 8–12 mm Hg reflects venous congestion / impaired renal outflow |
| Abdominal perfusion pressure (MAP − IAP) | Goal ≥ 60 mm Hg in intra-abdominal hypertension |
| IAP — normal | ≤ 12 mm Hg |
| IAP — intra-abdominal hypertension (IAH) | > 12 mm Hg |
| IAP — abdominal compartment syndrome (ACS) | > 20 mm Hg with new organ dysfunction |
In cardiorenal and critically ill patients, AKI is driven as much by venous congestion (a high CVP) as by a low MAP; optimizing renal perfusion pressure means raising the MAP and decongesting. In intra-abdominal hypertension, a low abdominal perfusion pressure predicts organ failure and may signal the need for decompression.
References
- Kirkpatrick AW, Roberts DJ, De Waele J, et al. Intra-abdominal hypertension and the abdominal compartment syndrome: updated consensus definitions and clinical practice guidelines from the World Society of the Abdominal Compartment Syndrome. Intensive Care Med. 2013;39(7):1190–1206.
- Mullens W, Abrahams Z, Francis GS, et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol. 2009;53(7):589–596.
- Ostermann M, Bellomo R, Burdmann EA, et al. Controversies in acute kidney injury: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference. Kidney Int. 2020;98(2):294–309.
